Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vasilios Sevastianos

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 5, 2003
Prevention of and treatment for hepatitis B virus infection after liver transplantation in the nucleoside analogues eraGeorge V Papatheodoridis, Vasilios Sevastianos, Andrew K Burroughs
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 1, 2026
Hepatic steatosis in adults on CFTR modulators is commonly associated with cardiometabolic criteria consistent with metabolic dysfunction-associated steatotic liver diseaseSofia Manioudaki, Larisa Vasilieva, Eleni Geladari, et al.
The American Journal of Gastroenterology|October 24, 2003
Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infectionEmanuel K Manesis, George V Papatheodoridis, Vasilios Sevastianos, et al.
Journal of Clinical Medicine|May 13, 2023
The Presence of Myosteatosis Is Associated with Age, Severity of Liver Disease and Poor Outcome and May Represent a Prodromal Phase of Sarcopenia in Patients with Liver CirrhosisEleni Geladari, Theodoros Alexopoulos, Meropi D Kontogianni, et al.
Medicina (Kaunas, Lithuania)|August 28, 2025
<i>Clostridioides difficile</i> Infections: Epidemiological and Laboratory Data from the Internal Medicine Departments of a Tertiary Care Hospital in Athens, Greece, During the Past DecadeDimitris Kounatidis, Edison Jahaj, Eleni V Geladari, et al.
Life (Basel, Switzerland)|December 30, 2025
Improvement of Cystic Fibrosis-Associated Liver Disease in Adults on Long-Term Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) ModulatorsSofia Manioudaki, Larisa Vasilieva, Eleni Geladari, et al.
Alimentary Pharmacology & Therapeutics|June 23, 2022
HERACLIS-TAF: a multi-centre prospective cohort study on 2-year safety and efficacy of tenofovir alafenamide in patients with chronic hepatitis B with renal and/or bone disorders or risksGeorge V Papatheodoridis, Kostas Mimidis, Spilios Manolakopoulos, et al.
Journal of Viral Hepatitis|June 20, 2026
HERACLIS_BLV_D: Adherence to Real-Life Therapy With Bulevirtide in Chronic Hepatitis DDimitra Lakiotaki, Margarita Papatheodoridi, Vasilios Sevastianos, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 16, 2025
HERACLIS_BLV_D: Increasing Response Rates During 2-Year Bulevirtide Real-Life Therapy in Chronic Hepatitis DMargarita Papatheodoridi, Vasilios Sevastianos, Kalliopi Zachou, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 5, 2003
Prevention of and treatment for hepatitis B virus infection after liver transplantation in the nucleoside analogues eraGeorge V Papatheodoridis, Vasilios Sevastianos, Andrew K Burroughs
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 1, 2026
Hepatic steatosis in adults on CFTR modulators is commonly associated with cardiometabolic criteria consistent with metabolic dysfunction-associated steatotic liver diseaseSofia Manioudaki, Larisa Vasilieva, Eleni Geladari, et al.
The American Journal of Gastroenterology|October 24, 2003
Significance of hepatitis B viremia levels determined by a quantitative polymerase chain reaction assay in patients with hepatitis B e antigen-negative chronic hepatitis B virus infectionEmanuel K Manesis, George V Papatheodoridis, Vasilios Sevastianos, et al.
Journal of Clinical Medicine|May 13, 2023
The Presence of Myosteatosis Is Associated with Age, Severity of Liver Disease and Poor Outcome and May Represent a Prodromal Phase of Sarcopenia in Patients with Liver CirrhosisEleni Geladari, Theodoros Alexopoulos, Meropi D Kontogianni, et al.
Medicina (Kaunas, Lithuania)|August 28, 2025
<i>Clostridioides difficile</i> Infections: Epidemiological and Laboratory Data from the Internal Medicine Departments of a Tertiary Care Hospital in Athens, Greece, During the Past DecadeDimitris Kounatidis, Edison Jahaj, Eleni V Geladari, et al.
Life (Basel, Switzerland)|December 30, 2025
Improvement of Cystic Fibrosis-Associated Liver Disease in Adults on Long-Term Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) ModulatorsSofia Manioudaki, Larisa Vasilieva, Eleni Geladari, et al.
Alimentary Pharmacology & Therapeutics|June 23, 2022
HERACLIS-TAF: a multi-centre prospective cohort study on 2-year safety and efficacy of tenofovir alafenamide in patients with chronic hepatitis B with renal and/or bone disorders or risksGeorge V Papatheodoridis, Kostas Mimidis, Spilios Manolakopoulos, et al.
Journal of Viral Hepatitis|June 20, 2026
HERACLIS_BLV_D: Adherence to Real-Life Therapy With Bulevirtide in Chronic Hepatitis DDimitra Lakiotaki, Margarita Papatheodoridi, Vasilios Sevastianos, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 16, 2025
HERACLIS_BLV_D: Increasing Response Rates During 2-Year Bulevirtide Real-Life Therapy in Chronic Hepatitis DMargarita Papatheodoridi, Vasilios Sevastianos, Kalliopi Zachou, et al.
Pageof 1